Toward a National System of Expanded Testing of Existing Urine Specimens: The Drug Outbreak Testing Service (DOTS)

References

• Billing, A. S., Artigiani, E. E., Robinson, J., Adatsi, F., & Wish, E. D. (2017). Community drug early warning system (CDEWS-3): Washington, DC – Site 3 of 4. Office of National Drug Control Policy. Executive Office of the President.
   Google Scholar
• Center for Substance Abuse Research (CESAR). (2018a). DOTS bulletin – Inaugural issue: Overview of the drug outbreak testing service pilot study. Retrieved November 5, 2020, from https://cesar.umd.edu/sites/cesar.umd.edu/files/dotsbulletin-issue1-june2018-methodology-final.pdf
   Google Scholar
• CESAR. (2018b). Drug-positive urine specimens from uninsured or publicly insured residents of Montgomery County, Maryland, contain no fentanyl and few synthetic cannabinoids but do contain multiple drugs. Retrieved November 5, 2020, from https://cesar.umd.edu/sites/cesar.umd.edu/files/dotsbulletin-issue4-june2018-accesstobh-final.pdf
   Google Scholar
• CESAR. (2018c). Methamphetamine: A regional drug crisis. Retrieved November 5, 2020, from https://cesar.umd.edu/publicationprofile/110
   Google Scholar
• CESAR. (2018d). Methamphetamine, but no fentanyl, found in opiate-positive specimens from a Corpus Christi, Texas, Residential Treatment Center; Multiple drugs found in every specimen. Retrieved November 5, 2020, from https://cesar.umd.edu/sites/cesar.umd.edu/files/dotsbulletin-issue7-august2018-charliesplacetx-final.pdf
   Google Scholar
• CESAR. (2018e). No fentanyl analogs but buprenorphine, naloxone, and marijuana detected in specimens from suspected users of fentanyl in Vermont. Retrieved November 5, 2020, from https://cesar.umd.edu/sites/cesar.umd.edu/files/dotsbulletin-issue6-july2018-aspenti-final.pdf
   Google Scholar
• CESAR. (2018f). Uninsured opioid users admitted to medication-assisted treatment (MAT) program in Palm Beach County, Florida, found to be using many drugs in addition to opioids. Retrieved November 5, 2020 from https://cesar.umd.edu/sites/cesar.umd.edu/files/dotsbulletin-issue5-july2018-palmbeach-mat-rev-final.pdf
   Google Scholar
• CESAR. (2019a). DOTS bulletins – De-identified urine testing. Retrieved November 5, 2020, from https://cesar.umd.edu/ndews/dots-bulletins-de-identified-urine-testing
   Google Scholar
• CESAR. (2019b). Drugs detected in emergency department patients with suspected opioid overdose who did not respond to typical doses of naloxone. Retrieved November 5, 2020, from https://cesar.umd.edu/sites/cesar.umd.edu/files/dotsbulletin-issue10-december2019-ohsu-final.pdf
   Google Scholar
• CESAR. (2019c). Gabapentin most common drug detected at Glen Burnie recovery house: “Gabapentin is replacing opioids and being misused.” Retrieved November 5, 2020, from https://cesar.umd.edu/sites/cesar.umd.edu/files/dotsbulletin-issue9-december2019-steppingstones-final.pdf
   Google Scholar
• CESAR. (2019d). Marijuana and opioids detected in a sample of specimens from gunshot wound victims. Retrieved November 5, 2020, from https://cesar.umd.edu/sites/cesar.umd.edu/files/dotsbulletin-issue11-december2019-pghc-final.pdf
   Google Scholar
• CESAR. (2020). Emergency department drug surveillance (EDDS) system. Retrieved November 11, 2020, from https://cesar.umd.edu/landing/EDDS
   Google Scholar
• Community Drug Early Warning System (CDEWS). (2020). Community drug early warning system (CDEWS). Retrieved November 5, 2020, from https://cesar.umd.edu/cdews/cdews-reports
   Google Scholar
• Compton, W. M., Valentino, R. J., & DuPont, R. L. (2021). Polysubstance use in the U.S. opioid crisis. Molecular Psychiatry, 26(1), 41–50. https://doi.org/10.1038/s41380-020-00949-3
   PubMed Web of Science ®Google Scholar
• Dezman, Z. D. W., Al-Nassir, M. F., Billing, A. S., Artigiani, E. E., & Wish, E. D. (2018). First DOTS study finds fentanyl and polydrug use in patients seen during opioid overdose spike in Baltimore – Higher doses of naloxone may be needed. Retrieved November 5, 2020, from https://cesar.umd.edu/sites/cesar.umd.edu/files/dotsbulletin-issue2-june2018-baltimore-midtown-final.pdf
   Google Scholar
• Diversion Control Division (DCD). ( n.d.). DEA TOX drug enforcement administration toxicology testing program. Retrieved February 8, 2021, from https://www.deadiversion.usdoj.gov/dea_tox/index.html
   Google Scholar
• DuPont, R. L., & Wish, E. D. (1992). Operation tripwire revisited. The Annals of the American Academy of Political and Social Science, 521(1), 91–111. https://doi.org/10.1177/0002716292521001006
   Web of Science ®Google Scholar
• Greenwood, V. (2021). Scientists are trying to spot new viruses before they cause pandemics. Retrieved February 16, 2021, from https://www.nytimes.com/2021/02/15/health/scientists-viruses.html
   Google Scholar
• Hoffer, L., Schlosser, A., & Buckelew, K. (2019). NDEWS HotSpot report - Fentanyl: User beliefs and practices – Cleveland, Ohio. Retrieved February 3, 2021, from https://ndews.org/publications/hotspot-reports/
   Google Scholar
• Krotulski, A. J., Varnum, S. J., & Logan, B. K. (2020). Sample mining and data mining: Combined real-time and retrospective approaches for the identification of emerging novel psychoactive substances. Journal of Forensic Sciences, 65(2), 550–562. https://doi.org/10.1111/1556-4029.14184
   PubMed Web of Science ®Google Scholar
• Lopez, A. M. (2019). The co-use of methamphetamine and opioids among patients in treatment in Oregon, USA. Retrieved February 3, 2021, from https://ndews.org/publications/hotspot-reports/
   Google Scholar
• Mars, S. G., Ondocsin, J., & Ciccarone, D. (2018). Sold as heroin: Perceptions and use of an evolving drug in Baltimore, MD. Journal of Psychoactive Drugs, 50(2), 167–176. https://doi.org/10.1080/02791072.2017.1394508
   PubMed Web of Science ®Google Scholar
• Moyer, P. (2019). Bio-Surveillance of non-fatal overdoses in Minnesota: A view a bit farther down the path-ology of substance use [Conference presentation]. Association of Public Health Laboratories (APHL) Annual Meeting, June 3. https://www.aphl.org/conferences/proceedings/Documents/Annual%20Meeting%202019/10Moyer.pdf
   Google Scholar
• Office for Human Research Protections. (2011). Attachment D: FAQ’s terms and recommendations on informed consent and research use of biospecimens. Retrieved February 20, 2020, from https://www.hhs.gov/ohrp/sachrp-committee/recommendations/2011-october-13-letter-attachment-d/index.html
   Google Scholar
• Office of National Drug Control Policy. (2014). ADAM II 2013 annual report. Retrieved February 20, 2020, from https://obamawhitehouse.archives.gov/sites/default/files/ondcp/policy-and-research/adam_ii_2013_annual_report.pdf
   Google Scholar
• Rosenblum, D., Unick, J., & Ciccarone, D. (2020). The rapidly changing US illicit drug market and the potential for an improved early warning system: Evidence from Ohio Drug Crime Labs. Drug and Alcohol Dependence, 208, 107779. https://doi.org/10.1016/j.drugalcdep.2019.107779
   PubMed Web of Science ®Google Scholar
• Sorg, M. H., Wren, J. A., Stewart, K., & Cao, Y. (2017). Unintentional fentanyl overdoses in New Hampshire: An NDEWS hotspot analysis. Retrieved February 3, 2021, from https://ndews.org/publications/hotspot-reports/
   Google Scholar
• The Center for Forensic Science Research and Education (CFSRE). (2021). NPS discovery. Retrieved February 8, 2021, from https://www.npsdiscovery.org/
   Google Scholar
• Wish, E. D. (1990). U.S. drug policy in the 1990s: Insights from new data from arrestees. The International Journal of the Addictions, 25(3A), 377–409. https://doi.org/10.3109/10826089009071049
   PubMedGoogle Scholar
• Wish, E. D., Billing, A. S., Artigiani, E. E., Dezman, Z., Schwartz, B., & Pueschel, J. (2018). Drug early warning from re-testing biological samples: Maryland hospital study. Office of National Drug Control Policy. Executive Office of the President.
   Google Scholar